SciELO - Scientific Electronic Library Online

 
vol.41 número1Compromiso de Asunción. Un llamado a la acción índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Nutrición Hospitalaria

versão On-line ISSN 1699-5198versão impressa ISSN 0212-1611

Resumo

MORENO-VILLARES, José Manuel  e  GRUPO DE ETICA DE SENPE* et al. Home parenteral nutrition in patients with malignant bowel obstruction. Ethical considerations. Nutr. Hosp. [online]. 2024, vol.41, n.1, pp.255-261.  Epub 07-Mar-2024. ISSN 1699-5198.  https://dx.doi.org/10.20960/nh.05042.

Background:

patients with cancer are one of the main group of patients on home parenteral nutrition (HPN). Patients with malignant bowel obstruction (MBO) represent a challenging group when considering HPN. At the Ethics Working Group of SENPE ethical considerations on this subject were reviewed and a guidelines proposal was made.

Methods:

a literature search was done and a full set of questions arose: When, if ever, is HPN indicated for patients with MBO? How should the training program be? When withdrawal of HPN should be considered? Other questions should be also taken into consideration. May any Oncologist send home a patient with HPN? The educational program could be shortened? When considering to withdraw parenteral nutrition?

Results:

HPN in MBO has better outcomes when patients have a good functional status (Karnofsky ≥ 50 or ECOG ≤ 2), expected survival > 2-3 months, and low inflammatory markers. Very few data have been reported on quality of life, but HPN allows a valuable time at home albeit with a considerable burden for both patients and their families.

Proposal:

once a patient is considered for HPN, there is a need for a deep talk on the benefits, complications and risks. In this initial talk, when HNP should be stopped needs to be included. The palliative care team with the help of the nutrition support team should follow the patient, whose clinical status must be assessed regularly. HPN should be withdrawn when no additional benefits are achieved.

Conclusion:

HPN may be considered an option in patients with MBO when they have a fair or good functional status and a desire to spend their last days at home.

Palavras-chave : Malignant bowel obstruction; Home parenteral nutrition; Advanced cancer; Futility; Palliative care.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )